These findings provide insights for developing novel APLNR inhibitors and establish a theoretical foundation for combination therapy strategies utilizing APLNR inhibitors to potentiate anti-tumor effects through inducing tumor vascular normalization. This evidence concerns the gene APLNR and neoplasm.